Drug induced pseudoporphyria in CKD: A case report
- Resource Type
- Authors
- Ruhi Khan; Anwar Salamat Khan; Saif Quaiser
- Source
- Indian Journal of Nephrology
Indian Journal of Nephrology, Vol 25, Iss 5, Pp 307-309 (2015)
- Subject
- medicine.medical_specialty
Pathology
congenital, hereditary, and neonatal diseases and abnormalities
Drug-induced pseudoporphyria
torsemide
business.industry
medicine.medical_treatment
Torsemide
Case Report
lcsh:Diseases of the genitourinary system. Urology
lcsh:RC870-923
medicine.disease
Dermatology
Pseudoporphyria
Nephrology
Chronic kidney disease
medicine
Porphyria cutanea tarda
business
skin and connective tissue diseases
Ultraviolet radiation
Dialysis
medicine.drug
pseudoporphyria
- Language
- English
- ISSN
- 1998-3662
0971-4065
Pseudoporphyria (PP) is used to describe a photodistributed bullous disorder with clinical and histologic features of porphyria cutanea tarda (PCT) but without accompanying biochemical porphyrin abnormalities. Medications, excessive sun and ultraviolet radiation exposure, have all been reported to develop PP. We report a case of PP in a 49-year-old man with CKD stage 3a, caused due to torsemide intake. This is probably the first reported case of PP developing in a dialysis naive patient CKD due to torsemide intake from India.